← All sarcoma trials
Recruiting now—All ages

Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors

Sponsor: Washington University School of Medicine · NCT03141021 on ClinicalTrials.gov ↗

Bring this to your care team →

Conditions studied

Malignant Peripheral Nerve Sheath Tumors

Where it's running13 sites

  • Moffitt Cancer Center

    Tampa, Florida 33612

    Completed

  • Johns Hopkins

    Baltimore, Maryland 21205

    Recruiting now
    • Christine Pratilas, M.D.(contact)410-955-8751
    • Christine Pratilas, M.D.(principal investigator)

  • National Institutes of Health (NIH)

    Bethesda, Maryland 20892

    Opening soon

  • Dana Farber Cancer Institute

    Boston, Massachusetts 02215

    Withdrawn

  • University of Minnesota

    Minneapolis, Minnesota 55455

    Withdrawn

  • Washington University School of Medicine

    St Louis, Missouri 63110

    Recruiting now
    • Angela Hirbe, M.D., Ph.D.(contact)(314) 362-8965[email protected]
    • Angela Hirbe, M.D., Ph.D.(principal investigator)
    • David Gutmann, M.D., Ph.D.(sub investigator)
    • Sonika Dahiya, M.D., MBBS(sub investigator)
    • Brian Van Tine, M.D., Ph.D.(sub investigator)
    • Peter Oppelt, M.D.(sub investigator)

  • Memorial Sloan Kettering Cancer Center

    New York, New York 10065

    Opening soon
    • Ping Chi, M.D., Ph.D.(contact)646-888-4166
    • Ping Chi, M.D., Ph.D.(principal investigator)

  • Lifespan

    Providence, Rhode Island 02903

    Completed

  • University of Utah

    Salt Lake City, Utah 84112

    Completed
4 international sites

  • Mount Sinai

    Toronto, Ontario, Canada M5T 3L9

    Recruiting now

  • Global Gene Corporation

    Mumbai, India

    Completed

  • Nagoya University Hospital

    Nagoya, Showa Ward, Japan

    Recruiting now

  • Royal National Orthopedic Hospital

    London, United Kingdom

    Terminated
See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria and Exclusion Criteria:

-Any patient diagnosed with an MPNST is eligible for enrollment to this registry provided s/he consents to participate (or consent form his/her parent or legal guardian or legally authorized representative is obtained).

Updated 2026-03-09 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.